http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201190133-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-34
filingDate 2010-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201190133-A1
titleOfInvention OPTICALLY ACTIVE DERIVATIVES 3 - [(PHENYLIPIPERAZIN-1-IL) ALKYL] -3-ALKYL-OXINDOL, possessing activity with respect to the central nervous system (CNS)
abstract The present invention relates to enantiomers of 5,7-dichloro-3- {4- [4- (4-chlorophenyl) piperazin-1-yl] butyl} -3-ethyl-1,3-dihydro-2H-indol-2-one formula (II), their pharmaceutically acceptable salts, a method for their manufacture, medicinal products containing these enantiomers, and their use and their pharmaceutically acceptable salts for the treatment of diseases of the central nervous system.
priorityDate 2009-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411698019
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11525867

Total number of triples: 22.